Bessler Robert 4

What Happened

• Robert Bessler, a director of LifeStance Health Group, sold a total of 5,101 shares in open-market transactions on April 21, 2026. The filing reports two disposals: 2,551 shares for $17,883 and 2,550 shares for $17,876, for total reported proceeds of $35,759. The reported weighted-average price was $7.01; the filing notes individual trade prices ranged $7.00–$7.02.
• This was a sale (not a purchase or option exercise). Sales by insiders are common for liquidity or portfolio reasons and do not by themselves signal company performance.

Key Details

• Transaction date: April 21, 2026; Form 4 filed April 23, 2026 (timely, two business days after trades).
• Reported prices: weighted average $7.01; actual trades ranged $7.00–$7.02 (Footnote F1).
• Reported proceeds: $17,883 and $17,876 (total $35,759).
• Shares owned after transaction: not specified in the information provided in this summary.
• Notable footnotes: F1 explains the weighted-average price and per-trade price range; F2–F4 state the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest, and F4 notes shares were held of record by Alpine Glow Capital, for which Bessler is manager and sole member.

Context

• This was an open-market sale (Form 4 code "S"). The filing does not indicate a 10b5-1 plan, an award, an option exercise, or tax-withholding in connection with these transactions.
• For retail investors: purchases are often more informative about insider confidence than routine sales. This report documents the disposal and the mechanics (weighted average price and record-holder structure) but does not provide a stated reason for the sale.